Polyalkylsulfonated C, , or FC,S, a highly water-soluble caged fullerene derivative, is believed to be a free radical remover or an antioxidant in biological systems. A 50 mg/ml aqueous solution was prepared as a master solution and administered to female Sprague-Dawley CD(Crl:CDE(SD)BR) rats in a single-dose acute toxicity study or a 12-day subacute toxicity study where rats were given the solution daily. In a study of the median lethal dose (LD,,), no rats died after oral administration, and thus FC,S was considered to nontoxic if administered orally. In an LD,, intraperitoneal injection study, rats died within 30 hr after injection; the LD,, was determined to be approximately 600 mg per kilogram of body weight. Rats injected with the compound intraperitoneally or intravenously immediately eliminated the compound through the kidney; the kidney appeared to be the primary target organ. The compound induced a distinct lysosome-overload nephrosis, a phagolysosomal nephropathy characterized by a tinctorial difference between the outer cortex and the inner cortex and the medulla. The affected outer cortex showed a diffuse degeneration, with the presence of numerous large vacuoles and cytoplasmic aggregates in the tubular epithelium. The phagolysosomal nephropathy was detected in rats after acute exposure as well as in the surviving rats following 1 intraperitoneal injection of 500 m g k g or intravenous injection of 100 m a g . Ultrastructural investigation revealed numerous membranous conglomerates characteristic of phagolysosomal and/or lysosomal inclusions in the cytoplasm of the renal tubular epithelium. These conglomerates were confined to the vacuole, electron-dense, and unevenly stained. They varied in size and shape and were fused or aggregated. Occasional phagolysosomes were also observed in the endothelial cells of the peritubular plexus. A preliminary study of microsomal enzyme activity analysis revealed a suppression effect of liver cytochrome P-4504ependent monooxygenase activities, including cytochrome P-450, cytochrome b,, and benzo(a)pyrene hydroxylase, but an increased level of kidney cytochrome P-4504ependent monooxygenase activities, including NADPH-cytochrome P-450 reductase. The significance of these enzyme alterations was not well determined. Further study is needed to clarify the correlation between the alterations of microsomal enzyme activity and the nephropathy of lysosomal overload-induced changes. These changes may serve as a biological marker in toxicity screening tests for this class of compound.
INTRODUCTION
Caged fullerene molecules and their analogues were 1996's Nobel Prize chemistry laureates trophy chemicals that exhibit high reactivity toward organic radical additions (23, 35) . To facilitate their medical and therapeutic applications as free radical removers or antioxidants in biological systems, conversion of hydrophobic C, into its water-soluble derivatives has been a primary research target for many investigators. The first generation of water-soluble fullerenes, as polyhydroxylated C, , was suc-.ceSsfully synthesized in 1992 (11, 12). This type of polyhydroxylated C, or fullerenol-l consists of a C, cage along with 18-OH moieties, which were known to be susceptible to the attack of highly reactive radicals. In fact, it'was proven to be a potent free radical scavenger (9) and is expected to be permissible for use for therapeutic and preventive purposes in biological antioxidative systems (8, 10, 18-20, 32, 34) . The second generation of water-soluble fullerene derivatives, such as polyalkylsulfonated C, with 4-6 sodium butyl sulfonate moieties, i.e., FC,S or C,((CH,),SO,Na),-,, was recently synthesized by Chiang et a1 (6; personal communication). It exhibits higher solubility in water and greater electron affinity as compared with those of polyhydroxylated C, . For further information regarding the possible toxicity of these water-soluble fullerene derivatives, a series of biological-toxicity evaluations on these synthesized hydrophilic C, molecules was performed.
A pilot study designed to study the median lethal dose (LD,,) was conducted in rats injected intraperitoneally (ip) with 1 dose (6). The preliminary results revealed that FC,S induced lysosomal overload in the kidney, a unique phagolysosomal nephropathy that may serve as a biological marker in toxicity screening tests for a series of synthesized water-soluble fullerenes. The present study was also designed to explore: (a) LD,, with oral administration, (b) acute toxicity with intravenous (iv) injection with lower doses, and (c) repeated dose subacute toxicity 143 0192-G233/98$3.00+$0.00 TOXICOLOGIC PATHOLOGY using ip injection of a lower dose of the compound over 12 days. A limited preliminary ultrastructural investigation and microsomal enzyme activity analysis was also conducted in some of these rats. This report presents the results of these investigations and comments upon FC,Sinduced phagolysosomal nephropathy.
MATERIALS AND METHODS Coriipoiiiid arid Ariinials. FC,S, a chemical compound synthesized by Chiang et a1 (6; personal communication) was dissolved in water to create a master solution of 50 mg/ml. All tests were conducted in female Sprague-Dawley CD(Crl:CD@(SD)BR) rats (Japan-origin Sprague-Dawley; Charles River, Japan, Atsuki, Kanagawa), which were purchased from the National Laboratory Animal Breeding and Research Center (Nankang, Taipei) and raised under special pathogen-free conditions. The animals were 5-6 wk old, weighed 145 5 15 g, and were housed in polycarbonate shoebox cages on hardwood bedding (6 rats per cage) under controlled conditions (temperature, 22 2 1°C; relative humidity, 55 2 15%; 12:12 hr 1ight:dark cycle). The rats were allowed free access to a laboratory rodent diet (#5L65, Purina Mills, Inc., St. Louis, MO), and water was available ad libitim.
Experimental Design. The study included 2 parts: 1 single dose acute toxicity study and a 12-day repeated dose subacute toxicity study. In the acute study, rats were administered a single oral dose at levels of 0 and 2,500 mg per kilogram of body weight, were given ip injection of 0, 500, 750, or 1,000 mgkg for LD,, evaluation, or were given iv injection of 0, 10, or 100 mgkg. Rats were allowed to survive 2 wk postdose before final sacrifice. In the subacute study, rats were given ip injections with 0, 0.6, 6, or 60 mgkg for 12 consecutive days and euthanatized 1 day after the last dose. Feed and water consumption per group were recorded daily. Individual animal body weights were collected on day 7 and on the last day before final sacrifice. Animals were euthanatized by carbon dioxide asphyxiation.
Toxicologic Pntliology. All surviving rats in the acute study and rats in the 12-day repeated dose study were subjected to necropsy for a toxicologic pathology evaluation that included measurement of final body weight, organ weight comparison, hematology and plasma biochemistry analyses, and ultrastructural investigation of the kidneys. At necropsy, the final body weight and organ weights, including the weights of the liver, kidneys, lungs, heart, and spleen were taken. Representative tissue samples of liver, kidneys, lungs, heart, and spleen, were taken; samples of any gross lesions were saved for histopathologic evaluation. In addition, the target organs from acute death rats were also saved for histopathology. In some trials, additional organs and tissues, including adrenals, thymus, and brain, were also included for evaluation. For selective investigation, small pieces of the kidneys were removed for electron microscopy, and the remaining liver and kidneys were rapidly frozen in liquid nitrogen for studies of their microcosms' enzyme activities. Blood samples were drawn for blood chemistry and hematologic analyses. The plasma chemistry analysis included .aspartate aminotransferase, alanine aminotrans-ferase, alkaline phosphatase, creatinine, total protein, albumin, blood urea nitrogen, triacrylglycerol, and glucose. The blood chemistry and hematology analyses were determined with a Hitachi 7050 Automatic Analyzer and and a Serono System 9000, respectively. The data were subjected to statistical analysis, with statistical significance estimated according to Duncan's multiple range test.
Tissues were fixed in 10% buffered formalin, embedded in paraffin, and processed for routine histology with hematoxylin and eosin stain. Special stains, including periodic acid-Schiff (PAS) and Grocott's methenamine silver nitrate (GMS), were applied whenever necessary. For ultrastructural investigation, the kidney tissue was diced into 1-mm cubes and prefixed in 2.5% glutaraldehyde for 2 hr, washed with 5% sucrose/O.l M sodium phosphate buffer (pH 7.4) at 4"C, and postfixed in 1% osmium tetroxide. The tissues were further processed for thin sections, stained with uranyl acetate and lead citrate, and examined with a Zeiss TEM 900.
Microsonid Erizyme Activity Aiinlysis. Preliminary tests for microsomal enzyme activity were performed on the liver and kidney. The liver was removed from rats given a single ip injection of FC,S at a dose level of 500 mgkg. Rats were allowed to survive for 14 days after their final dose. The kidney was removed from the rats given 12-day repeated dose via ip injection at 0.6,6, and 60 mgkg. Animals were euthanatized 1 day after the last dose was administered.
The rapidly frozen liver and kidney tissues were thawed, rinsed, and homogenized in an ice-chilled 1.15% KCl solution. Washed hepatic or renal microsomes were prepared by differential centrifugation (2) and used monooxygenase assays. The effects of FC,S on cytochrome P-45O-dependent monooxygenases were assayed on the content of cytochrome P-450 and cytochrome b5 (29) , the activity of NADPH-cytochrome P-450 reductase (30), benzo(a)pyrene hydroxylase activity (28), ethoxycoumarin 0-deethylase (1 5 ) , aniline hydroxylase (21) , erythromycin N-demethylase activity (27) , and the content of microsomal protein (25) . The microsomal enzyme activity data were subjected to statistical analysis using Student's f-test.
RESULTS

Acute Study
DJo Study. No rats died after the oral administration of FC,S. Thus, the compound was considered nontoxic when administered orally.
After ip injection, most rats in the 750 and 1,000 m g k g group were quiet and inactive. Rats died approximately 7 hr after injection. The majority of rats in the 750 mgkg dose group (5 rats) and the 1,000 mgkg dose group (6 rats) died within 24 hr following the injection. Two rats, 1 each in the 500 and 750 mgkg group, died 27 and 30 hr after the injection, respectively. The LD,, was therefore defined as approximately 600 mgkg (6,7). The gross examination of acute death rats revealed pale kidneys along with other nonspecific, systemic-related toxic effects. The kidneys were believed to be the target organ and therefore were saved for histologic evaluation. The remaining 5 rats in the 500 mgkg group survived 14 days postdose. No gross observation was noted in the 5 surviving rats, but a statistically significant decrease in final body weight gain and spleen weight were noted. The remaining organ weight alterations were considered to be biologically insignificant.
Microscopic examination of kidneys from rats in the acute death group revealed a diffuse, massive necrosis of the tubular epithelium in the outer cortex, including all proximal and distal convoluted tubules (Figs. 1 and 2). The labyrinth portion of the renal cortex was uniformly affected, with aparing of the medullary rays and renal medulla. Although the cells were completely lysed, GMS staining demonstrated that the tubular basement membranes appeared intact. Less necrosis and intensive vacuolar degeneration of renal tubular epithelium were present in 2 rats that died more than 24 hr after injection. This degenerated tubular epithelium had numerous cytoplasmic vacuoles containing granular cores that did not react to PAS staining. These core-containing vacuoles were believed to be phagolysosomes, and therefore the kidney change was designated as phagolysomal nephrosishephropathy (7). a sequestrum of lysosome overload.
The phagolysosomal nephrosis was still present in 4 of the 5 surviving rats 14 days postdose. The nephrosis was characterized as a diffuse tubular degeneration involving the entire outer cortex, with numerous vacuoles and phagolysosomes ( Fig. 3) . Again, the inner cortex and medulla were tinctorially different from the outer cortex labryinth. Well-preserved brush borders were frequently observed in the very inner portion of the cortical tubules. The tubules were equivalent to the S3 segment or the pars recta of the proximal convoluted tubules (5). The liver, spleen, and thymus had many light brown, pigment-laden cells or granules indicating phagocytized macrophages. No compound-induced effect on blood cells or serum biochemical functions were detected.
Single Dose Iiitravenoris Injection Stridy. The rats scarified 2 wk after treatment with 1 dose iv injection of FC,S of 100 mgkg had phagolysosomal nephropathy similar to that observed in the acute ip injection study, but the degree of vacuolar degeneration or phagolyso-soma1 formation was less intense. The histopathologic effects were moderate. In addition, statistically and biologically significant decreases in alkaline phosphatase and triacylglycerol were noted in this group of rats. The remaining biochemical alterations were not considered to be biologically significant. There was no hematologic ef- fect. No compound-related effect was present in rats treated with 10 mgkg FC,S.
Srrbociite Study
Twelve-Day Repented Iiitraperitoiienl Iiljectioii Study. Clinically, rats given daily ip injection of 60 mgkg FC,S consumed less food and water. The clinical effect was noted on the third day of treatment; less water and feed consumption was noted in the rats in this group. A sub-stantial loss of body weight was noted in the first week of the study. Approximately 52% less water and 30% less feed was consumed at the end of the 12 repeated daily doses, in comparison with control rats. Following the 12 daily doses, significant decreases in final body weight, thymus weight, and heart weight were found, but an increase in spleen weight was observed in these rats (Tables  I and 11 ). Statistically and biologically significant increases in aspartate aminotransferases and decreases in triacylglycerol levels were the only changes present in the plasma biochemical analysis (Table 111) .
Compound-related histopathologic effects of phagolysosomal nephropathy were observed in the rats in the 6 and 60 mgkg groups, although the nephoropathy was less intensive in the rats in the 6 mgkg group. Moreover, frequent clusters of brownish granule-laden macrophages were observed in the splenic red pulp, lymph node lymphatics, thymus, and liver sinusoids. No compound effect was observed in the rats in the 0.6 mgkg group.
To summarize the acute and subacute toxicity studies, in addition to the induced phagolysosomal nephrophathy, other significant compound-related effects were final body weight and serum triacylglycerol decreases. These effects were noted in the 14-day postdose rats following 1 dose of 100 mgkg iv injection and the 1-day postdose rats following 12-day repeated dose of 60 mgkg ip injection. Actually, the decrease was noted in rats from the third or fouth day. Body weight effect was also noted in the 14 days following 1 dose of 500 mgkg ip injection. There were no plasma biochemical alterations indicative of kidney impairment. Statistically significantly increased asparate aminotransferase was noted in the rats given 60 mgkg of the compound, but no morphologic evidence of liver damage was noted.
Ultrastnrctitrnl Investigntion of Pl~ngolysoso~nal Nepli ropntliy
Transmission electron microscopy was performed on the kidneys from rats given iv injection of 100 mgkg FC,S and ip injection of the same compound in 60 mgkg doses given once a day for 12 days. There were numerous phagolysosomal complexes or lysosomal inclusions in the renal proximal tubule epithelium that varied in size and electron density (Fig. 4) . These complexes and inclusions were mostly confined to the cytoplasmic vacuoles or vesicles and, on rare occasions, in the cytoplasm. Many vac- uoles were confined with double plasma membranes, but some were not. These complexes or inclusions were fused aggregates and conglomerates that were composed of numerous small membranous, laminated, circled band bodies varying in size and exhibiting uneven electron density. A few inclusions appeared to be heterolysosomes, and some were whorl-like, membranous residues or bodies (Fig. 5 ). The inclusions in the vacuoles were similar to membrane-bound lysosomal bodies with translucent backgrounds. The origin of the inclusions and the mechanisms involved were not clear but appeared to be quite possibly lysosome related. Occasionally, some nonelectron-dense, granular, membranous, or somewhat flocculent contents were beside the electron-dense bodies seen inside the vacuoles (Fig. 5) . The cells affected with heavily loaded vacuoles were mostly proximal, convoluted, tubular epithelium rich in mitochondria with wellformed brush borders. There were vesicles and small vacuoles on the luminal surface or apical portion of the tubular epithelium that were frequently confined with a small electron-dense core or displayed lysosome inclusion indicative of phagolysosomal origin (Fig. 6 ). Rarely, inclusions were also detected in other portions of the tubule epithelium and in nontubular cells, such as peritubular vascular endothelia (Fig. 7) .
Microsoniol Eiizynie Activity Alterotiom
A statistically significant decrease in liver enzyme components of microsomal protein content (22%), cytochrome P-450 (26%), cytochrome b5 (ll%), and benzo(a)pyrene hydroxylase (54%) were noted in rats given FC,S at the dose level of 500 mgkg (Table IV) . The NADPH-cytochrome P-450 reductase was also decreased, but this was not significant. Microsomal analysis of the kidney revealed an increase in microsomal protein content (16%), which was noted in rats given the 12-day repeated dose of 60 mgkg, and an increase in NADPHcytochrome P-450 reductase in all 3 groups of treated rats (Table V) . The increase of NADPH-cytochrome P-450 reductase was 6-to 8-fold more than that of the control rats. A 14% increase in kidney protein content was noted in the 6 mgkg group rats, and although this finding was not statistically significant, it was considered to be biologically significant, as it was similar to that seen in the rats in the 60 m g k g study group. The enzymatic activities of ethroxycoumarin 0-deethylase and benzo(a)pyrene hydroxylase detected in the kidney were either nonexistent or not obvious.
DlSCuSSlON
Polyalkylsulfonated C, and polyhydrooxygenated C, are water-soluble fullerene derivatives synthesized by Chiang and associates (6, 11, 12; personal communication) that have been demonstrated to scavenge oxygen radicals in virro (9). These synthesized fullerenes have been proven to be suitable candidates for the application as water-soluble antioxidants in the biological system (9, 10, 19, 20, 34) . An acute study in rats and mice with 1 dose given via ip injection or oral administration and a subacute study in rats injected with repeated ip or iv doses indicated that the LD,, in rats was approximately 600 mgkg (6) and 1,000 mgkg in mice (36) . No effect was induced in rats when the compound was administered orally. The kidney is considered to be the primary target organ. It eliminates the compound and develops phagolysosomal nephropathy (6, 7) . This phagolysosomal nephropathy is distinct and unique and may serve as a biological marker in toxicity screening tests for a series of synthesized water-soluble fullerenes. The compound induced renal effects in rats only after injection. With 1 dose given via iv injection, renal effects were detected in rats at a dose of 100 mgkg but not at a dose of 10 mgkg.
With daily doses repeated for 12 days or more, ip injection of 6 mgkg and above-but not at 0.6 mgkg-resulted in renal effects. These results suggest that an accumulative dose of up to 72 mgkg also resulted in kidney alteration.
The phagolysosomal nephropathy was characterized by the presence of vacuolar degeneration in the tubular epithelium of the outer cortex primarily affecting the labyrinth portion of the proximal and distal convoluted tubules. The renal effects detected using light microscopy were confirmed by electron microscopy as the presence of phagolysosomal complexes and lysosomal inclusions, mostly found within cytoplasmic vacuoles. These complexes and inclusions were numerous, varied in size, and were morphologically unique. The formation of these loaded complexes contrasted with the larger ones composed of numerous smaller inclusions, which appeared to be in different stages of development or formation. It appeared that many were sequestered in residual bodies and were formed by fusion and conglomeration of smaller ones.
The vacuolar inclusions in the epithelium of these FC,S-treated rat kidneys appeared to be similar to the nephrosis that occurred as a result of lysosomal overload (1). These kidneys exhibited phagolysosome-loaded renal tubular epithelia, as observed in the present study. These findings are also observed in lysosomal overload nephrosis induced by gentamicin aminoglycoside antibiotics (22), glucose, sucrose, mannose, or dextran (26, 13), contrast medium (3, 33), or a2u-globulin (4). These inclusions, however, are not identical morphologically, pathogenetically, or mechanistically. For example, in gentamicin-induced aminoglycoside antibiotic lysosomal overload nephrosis, the appearances of phagolysosomal bodies were meyloid bodies (1, 22) . Gentamicin is taken into the cell by endocytosis. Next, the endocytic vesicles fuse with phagosomes, and within the phagolysosomes, the drug and phospholipid membranes accumulate in the phagolysosome. Ultrastructurally, they appear as myeloid bodies. In kidneys in which glucose or anther similar compound is induced, osmotic nephrosis is referred to as the clinical effect because the glucose reabsorbed by pinocytosis leads to vacuolization of proximal covoluted tubules (26, 13).
Formation of phagolysosomal complexes in the renal tubular epithelium of the FC,S-treated rat kidneys was believed to develop primarily from the glomerular filtration for the elimination of the compound rather than from hematogenous toxic effects. The acute tubular degeneration manifested as phagolysosomal nephropathy induced in the present study might be categorized as nephrotoxic acute tubular necrosis or degeneration. The nature of these soluble C,-induced vacuoles and inclusions was not determined but was believed to be some component of the compound. Whether these phagolysosomal complexes represent a Cm component needs further investigation. Other possible origins of phagolysosomes were some probably degradated exogenous molecules taken up A further study to elucidate pathogenesis and the mechanism of formation of these inclusions is of interest.
Although morphologically convoluted tubular damage was noted in the FC,S-treated rat kidneys, the functional impact of this change was minimal, as there was a lack of serum biochemical evidence that indicated renal damage. The direct cause of the decrease in body weight was not well understood, although the decrease in serum triacylglycerol levels was believed to be attributable to the body weight decrease. Triacylglycerols are excreted from the liver, and a decrease in serum triacylglycerol levels usually indicates that the hepatocyte's ability to synthesize lipoproteins is impaired (24) . This issue may create a new scope of investigation regarding water-soluble C, effects on lipid metabolism and its consequent effect on body weight in the biological system.
Study of FC,S on liver microsomal monooxygenase activity demonstrated that suppression of several cytochrome P-4504ependment enzyme activities were noted in female rats given 1 dose of FC,S 14 days after treatment. The enzymes affected were cytochrome P-450, cytochrome b,, and benzo(a)pyrene hydroxylase. A recent study of pretreated mice after ip administration of fullerenol-1, i.e., water-soluble polyhydroxylated C, , revealed similar suppression effects on liver microsomal enzyme activity (36) . These affected liver enzymes are responsible for the detoxification and bioactivation of many drugs and carcinogens (16, 3 1). The uniform suppression of the enzyme components suggests that these hydrophilic C, (FC,S and fullerenol-1) compounds are rather general inhibitors of P-450 in vivo. Because C, is a strained and electron-deficient molecule (14), the electron-negative hydrophilic C, is therefore believed to act as an artificial electron acceptor and decrease the flow of the reducing equivalent from NADPH via NADPH-cytochrome P-450 reductase to the terminal oxidase of the microsomal electron transport chain (36) . Two steps in the P-450 catalytic cycle can attract electrons, and therefore any impairment of these steps can lead to inhibition of the monooxygenase activity (17) . The hydroxylated C, compound may inhibit the catalytic activity of the microsomal enzymes by binding to the active site of P-450 or direct interaction with the P-450 molecule to cause conformational changes to decrease the catalytic activities (36) .
The effects of FC,S on kidney microsomal monooxygenase activity demonstrated a unique 6to 8-fold increase of the NADPH-cytochrome P-450 reductase in all treated rats at dose levels of 0.6, 6, and 60 mgkg. This is the first report to demonstrate induction of the kidney P-450-dependent monooxygenase activities by hydrophilic C, in vivo. Microsomal protein content also increased and was statistically significant in the rats in the 60 mg/kg,study group. The proliferative effects of FC,S on kidney -microsoma1 enzymes was opposite to the suppressive effects on liver microsomal enzymes in the present study and also in mice (36) . The mechanism of this increase was not well understood but was believed to be the result of de rzovo synthesis or a proliferative result from the massive formation of phagolysosomal inclusions in the renal tubular epithelium.
In conclusion, administration of FCJS via injection in rats resulted in rapid elimination of the compound through renal glomerular filtration and consequently affected the kidney as phagolysomal nephropathy. The effect on the kidney may serve as a biological marker in toxicity screening tests for a series of soluble C, compounds.
